| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ABBOTT LABORATORIES | EVP AND GROUP PRESIDENT | Common shares without par value | 146,377 | $16,918,253 | $115.58 | 02 Mar 2026 | Direct |
| ABBOTT LABORATORIES | EVP AND GROUP PRESIDENT | Option (right to buy) | 89,226 | 24 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27 Feb 2026 | 2 | -$871,348 | 4 | EVP AND GROUP PRESIDENT | 03 Mar 2026, 20:10 |
| ABT | ABBOTT LABORATORIES | 24 Feb 2026 | 2 | $0 | 4 | EVP AND GROUP PRESIDENT | 26 Feb 2026, 19:02 |
| ABT | ABBOTT LABORATORIES | 11 Dec 2025 | 1 | -$189,358 | 4 | EVP AND GROUP PRESIDENT | 12 Dec 2025, 17:04 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2025 | 1 | -$1,149,732 | 4 | EVP AND GROUP PRESIDENT | 04 Mar 2025, 19:54 |
| ABT | ABBOTT LABORATORIES | 25 Feb 2025 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 27 Feb 2025, 18:47 |
| ABT | ABBOTT LABORATORIES | 30 Jan 2025 | 3 | -$2,141,767 | 4 | EXECUTIVE VICE PRESIDENT | 31 Jan 2025, 19:08 |
| ABT | ABBOTT LABORATORIES | 29 Feb 2024 | 2 | -$1,179,439 | 4 | EXECUTIVE VICE PRESIDENT | 04 Mar 2024, 19:18 |
| ABT | ABBOTT LABORATORIES | 21 Feb 2024 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 23 Feb 2024, 17:43 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2023 | 2 | -$1,007,389 | 4 | EXECUTIVE VICE PRESIDENT | 02 Mar 2023, 18:52 |
| ABT | ABBOTT LABORATORIES | 17 Feb 2023 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 22 Feb 2023, 18:18 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2022 | 2 | -$1,474,713 | 4 | EXECUTIVE VICE PRESIDENT | 02 Mar 2022, 18:58 |
| ABT | ABBOTT LABORATORIES | 18 Feb 2022 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 23 Feb 2022, 19:28 |
| ABT | ABBOTT LABORATORIES | 23 Dec 2021 | 5 | -$5,890,766 | 4 | EXECUTIVE VICE PRESIDENT | 28 Dec 2021, 16:20 |
| ABT | ABBOTT LABORATORIES | 13 Dec 2021 | 6 | -$5,597,991 | 4 | EXECUTIVE VICE PRESIDENT | 15 Dec 2021, 17:34 |